In Vitro Diagnostic (IVD) devices encompass a wide range of applications such as molecular diagnostics, immunoassays, Remote Patient Monitoring (RPM) and point-of-care (POC) testing. These diagnostic tools are integral to our mission, enabling healthcare providers to detect and monitor diseases like cancer, infectious diseases, and genetic disorders with precision and reliability.
New IVD developers face technical challenges such as ensuring high sensitivity and specificity, achieving rapid turnaround times, and maintaining cost-effectiveness for widespread adoption. Additionally, the integration of advanced technologies such as novel sensors, next-generation sequencing and digital PCR presents opportunities and complexities in equal measure. Regulatory compliance and navigating the evolving landscape of global health standards are also critical.
Emerging trends such as personalised medicine and the increasing demand for home-based testing solutions are reshaping the IVD market. Meanwhile, the rise of connected diagnostics, which leverage data analytics and cloud computing, holds promise for more proactive and informed healthcare decisions, despite the barriers raised by data security and interoperability.
“Perdigó's expertise in healthcare engineering and product development was crucial to the progress of our device. Their technical knowledge, flexibility, and total dedication were invaluable, and were essential in ensuring the successful development of the device.”
